Novel Drug Delivery Systems (NDDS) Market
Novel Drug Delivery Systems (NDDS) Market Analysis By Route (Oral, Injectable, Pulmonary, Transdermal Drug Delivery Systems) By Mode (Targeted, Controlled & Modulated Drug Delivery Systems) and By Region – Global Market Insights 2022 to 2027
Analysis of Novel Drug Delivery Systems (NDDS) market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Novel Drug Delivery Systems (NDDS) Market Outlook
Worldwide demand for novel drug delivery systems (NDDS) is predicted to surge at a CAGR of 6.6% from 2022 to 2027. At present, the global novel drug delivery systems market enjoys a valuation of US$ 62.5 billion and is anticipated to climb to a market size of US$ 86 billion by the end of 2027.
Oral drug delivery systems are projected to be extremely popular over the coming years owing to their ease of administration and the increasing patient-centric approach of the healthcare sector.
| Report Attributes | Details |
|---|---|
| Novel Drug Delivery Systems Market Size (2022) | US$ 62.5 Billion |
| Projected Year Value (2027F) | US$ 86 Billion |
| Global Market Growth Rate (2022 to 2027) | 6.6% CAGR |
| Key Companies Profiled | AstraZeneca PLC; Boston Scientific; Genzyme Co.; Bayer AG; Novartis AG; Pfizer Inc.; Sanofi SA; Tolmar; GlaxoSmithKline PLC; Johnson & Johnson; Astellas; Aspen; Lupin; Breckenridge Pharmaceuticals; Shire; Galen; 3M Company; Merck & Co. Inc.; Teva Pharmaceuticals Industries Limited; Abbott Laboratories |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Demand Analysis of Novel Drug Delivery Systems (2017 to 2021) in Comparison to Market Growth Forecasts (2022 to 2027)
Drug delivery plays a crucial role in the treatment of any disease and hence has been a crucial aspect of the overall healthcare infrastructure. Conventional drug delivery systems are being replaced with advanced and modern drug delivery systems owing to their better efficacy and accuracy. This is expected to drive the novel drug delivery systems market at a CAGR of 6.6% over the next five years.
Increasing prevalence of chronic illnesses, rapid advancements in drug delivery technology, rising investments in the healthcare industry, favorable reimbursement policies, increasing R&D activities, the growing popularity of minimally invasive procedures, and advancements in drug formulation are expected to be prime factors that head the novel drug delivery systems market growth throughout the forecast period.
However, strict regulatory mandates are expected to have a constraining effect on the overall novel drug delivery systems market growth over the years to come. High costs of advanced healthcare procedures and lack of awareness of novel systems for drug delivery are other factors that could potentially restrain NDDS market growth to some extent over the next five years.
Which Prospects are Shaping NDDS Market Growth Path?
“Increasing Use of Drug Delivery Technology to Treat Chronic Diseases”
Drug delivery has been a crucial aspect of treatment for many diseases and with advancements in drug delivery, it has become more important in the treatment of most health conditions. The prevalence of chronic diseases such as cancer has increased exponentially over the past few years and this has led to high demand for novel systems for the delivery of drugs for the treatment procedures.
Drug delivery technology has offered some breakthrough treatment approaches for chronic diseases such as cancer and increasing research and development activities are expected to further advance the use of drug delivery in the treatment of other chronic illnesses.
“Stringent Regulatory Laws May Dwarf NDDS Market Potential”
Drug delivery systems need to undergo a crucial process of approval from regulatory bodies to be launched and used in the market. The presence of strict norms in the process of approval creates a challenge and hinders the overall novel drug delivery systems market potential. This factor is expected to maintain its restraining effect on the industry over the next five years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regional Market Leads Novel Drug Delivery System Demand?
“North America to Majorly Drives Novel Drug Delivery System Sales”
North America novel drug delivery systems market currently accounts for a major market share and is anticipated to maintain a similar stance throughout the forecast period.
Rising healthcare expenditure, supportive government initiatives, and the presence of key drug delivery system providers are the prime factors that are expected to drive NDDS market growth in this region through 2027.
Increasing investments in the healthcare industry and the emergence of new molecular diagnostic companies in Europe are expected to be major factors that positively influence novel drug delivery system demand.
Rising incidence of chronic illnesses is also expected to favor NDDS market growth through 2027. Germany, Italy, Spain, France, and the United Kingdom are projected to be prime markets for novel drug delivery systems companies in this region.
The novel drug delivery systems market in the Asia Pacific region is expected to provide highly lucrative opportunities in the coming years. Increasing focus on healthcare, rising investments in R&D activities, growing demand for minimally invasive procedures, and increasing availability of modern drug delivery systems are anticipated to be key prospects that drive novel drug delivery systems market potential in this region.
China and India are anticipated to be the prime markets in this region owing to supportive government initiatives and rising investments in the healthcare research and development sector. Japan is also expected to be a noteworthy market in the APAC region over the next five years.
Analysts at Fact.MR, a market research and competitive intelligence provider, have created a comprehensive novel drug delivery systems market research report that lists all the crucial insights of the industry on a regional and segmental basis.
Country-wise Insights
How Can Manufacturers Earn Profits from the U.S. Market?
“Supportive Government Initiatives to Boost R&D Activities & High Healthcare Expenditure”
The market for novel drug delivery systems in the United States is expected to be primarily driven by increasing research and development activities in the country. Increasing investments in the R&D sector by the government and rising healthcare expenditure in the U.S. are also expected to favor novel drug delivery systems market potential through 2027.
Increasing availability of various drug delivery systems and the high prevalence of chronic diseases such as cancer are also anticipated to bolster novel drug delivery systems market growth in the country throughout the forecast period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Mode of Drug Delivery Will Be Popular Going Forward?
“Controlled Drug Delivery Systems to Maintain Dominant Market Stance”
The global novel drug delivery systems market based on mode is bifurcated into controlled drug delivery systems, targeted drug delivery systems, and modulated drug delivery systems.
Controlled drug delivery systems are anticipated to be widely preferred across the world over the coming years. The ability to offer controlled drug release from these delivery systems helps maximize the efficacy of the drug and is also pivotal in controlling drug toxicity. Improved patient outcomes are also expected to boost demand for controlled drug delivery systems across the forecast period.
Meanwhile, the demand for targeted drug delivery systems is projected to rise at the fastest CAGR through 2027. The increasing use of targeted drug delivery systems in cancer treatment is expected to drive their demand over the years to come.
Which Route of Administration is Popular in NDDS?
“Oral Drug Delivery Systems to Lead NDDS Market Potential”
The global novel drug delivery systems market, based on route, is segmented into oral drug delivery systems, injectable drug delivery systems, pulmonary drug delivery systems, transdermal drug delivery systems, and others.
High patient compliance is a major factor that drives the popularity of oral drug delivery systems across the world. Other factors that benefit the demand for oral drug delivery systems are ease of production and formulation, ease of administration, hassle-free storage, etc. This segment provides lucrative opportunities in the novel drug delivery systems marketplace over the coming years.
Novel ocular drug delivery systems and novel ophthalmic drug delivery systems are anticipated to witness a rise in popularity throughout the forecast period as advancements in the drug delivery industry pick up the pace.
Competitive Landscape
Key companies in the novel drug delivery systems market are expected to bolster their focus on the launch of new and modern drug delivery systems equipped with advanced technologies.
- In June 2022, Gulfic Biosciences Ltd., an innovative pharmaceutical company, announced the launch of a new drug delivery system. The new drug delivery system technology was developed by Gulfic and its French counterpart at an affordable price. The new system is called Dual Chamber Bags (DCB).
- In May 2022, Jabil Healthcare, a leading name in the healthcare industry, announced the launch of a reusable drug delivery device with a broader spectrum of applications. The Qfinity Autoinjector Platform will be available at lower costs than its market alternatives and is expected to further bolster the sustainability trend in the drug delivery industry owing to its reusable nature.
NDDS market players are also expected to eye acquisitions, partnerships, and mergers to enhance their business scope and expand their market presence across the world.
- Bayer, a German biotechnology and pharmaceutical organization, in August 2021, announced the acquisition of Vividion Therapeutics to strengthen its portfolio of novel drug discovery platforms. The acquisition was valued at US$ 1.5 billion.
- In June 2022, Accord Biopharma and EVERSANA partnered to launch the CAMCEVI (leuprolide) 42mg injection emulsion that is expected to be used for the treatment of prostate cancer in adults.
Key Segments of NDDS Industry Research
-
By Route :
- Oral Drug Delivery Systems
- Injectable Drug Delivery Systems
- Pulmonary Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Others
-
By Mode :
- Targeted Drug Delivery Systems
- Controlled Drug Delivery Systems
- Modulated Drug Delivery Systems
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Route
- 9.1. Oral Drug Delivery Systems
- 9.2. Injectable Drug Delivery Systems
- 9.3. Pulmonary Drug Delivery Systems
- 9.4. Transdermal Drug Delivery Systems
- 9.5. Others
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Mode
- 10.1. Targeted Drug Delivery Systems
- 10.2. Controlled Drug Delivery Systems
- 10.3. Modulated Drug Delivery Systems
- 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 17. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 18. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 19. Key and Emerging Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. AstraZeneca PLC
- 21.2. Boston Scientific
- 21.3. Genzyme Co.
- 21.4. Bayer AG
- 21.5. Novartis AG
- 21.6. Pfizer Inc.
- 21.7. Sanofi SA
- 21.8. Tolmar
- 21.9. GlaxoSmithKline PLC
- 21.10. Johnson & Johnson
- 21.11. Astellas
- 21.12. Aspen
- 21.13. Lupin
- 21.14. Breckenridge Pharmaceuticals
- 21.15. Shire
- 21.16. Galen
- 21.17. 3M Company
- 21.18. Merck & Co. Inc.
- 21.19. Teva Pharmaceuticals Industries Limited
- 21.20. Abbott Laboratories
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route /p>
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Route
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Mode
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2021
Figure 02: Global Market Volume Forecast (in 000' Units), 2022 to 2027
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2021
Figure 06: Global Market Value Forecast (US$ Mn), 2022 to 2027
Figure 07: Global Market Absolute $ Opportunity, 2022 to 2027
Figure 08: Global Market Share Analysis (%), By Route, 2022 to 2027
Figure 09: Global Market Y-o-Y Analysis (%), By Route, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Route, 2022 to 2027
Figure 11: Global Market Share Analysis (%), By Mode, 2022 to 2027
Figure 12: Global Market Y-o-Y Analysis (%), By Mode, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 14: Global Market Share Analysis (%), By Region, 2022 to 2027
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value Share, By Route, 2022 (E)
Figure 18: North America Market Value Share, By Mode, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 21: North America Market Value Forecast (US$ Mn), 2022 to 2027
Figure 22: North America Market Attractiveness Analysis by Route, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 25: Latin America Market Value Share, By Route, 2022 (E)
Figure 26: Latin America Market Value Share, By Mode, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 29: Latin America Market Value Forecast (US$ Mn), 2022 to 2027
Figure 30: Latin America Market Attractiveness Analysis by Route, 2022 to 2027
Figure 31: Latin America Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 32: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 33: Europe Market Value Share, By Route, 2022 (E)
Figure 34: Europe Market Value Share, By Mode, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2021
Figure 37: Europe Market Value Forecast (US$ Mn), 2022 to 2027
Figure 38: Europe Market Attractiveness Analysis by Route, 2022 to 2027
Figure 39: Europe Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 41: South Asia Market Value Share, By Route, 2022 (E)
Figure 42: South Asia Market Value Share, By Mode, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 45: South Asia Market Value Forecast (US$ Mn), 2022 to 2027
Figure 46: South Asia Market Attractiveness Analysis by Route, 2022 to 2027
Figure 47: South Asia Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 48: South Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 49: East Asia Market Value Share, By Route, 2022 (E)
Figure 50: East Asia Market Value Share, By Mode, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 53: East Asia Market Value Forecast (US$ Mn), 2022 to 2027
Figure 54: East Asia Market Attractiveness Analysis by Route, 2022 to 2027
Figure 55: East Asia Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 56: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 57: Oceania Market Value Share, By Route, 2022 (E)
Figure 58: Oceania Market Value Share, By Mode, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2021
Figure 61: Oceania Market Value Forecast (US$ Mn), 2022 to 2027
Figure 62: Oceania Market Attractiveness Analysis by Route, 2022 to 2027
Figure 63: Oceania Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 64: Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 65: Middle East and Africa Market Value Share, By Route, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By Mode, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2021
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2022 to 2027
Figure 70: Middle East and Africa Market Attractiveness Analysis by Route, 2022 to 2027
Figure 71: Middle East and Africa Market Attractiveness Analysis by Mode, 2022 to 2027
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2022 to 2027
Figure 73: U. S. Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Market Value Share, By Route, 2022 (E)
Figure 75: U. S. Market Value Share, By Mode, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Market Value Share, By Route, 2022 (E)
Figure 78: Canada Market Value Share, By Mode, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Market Value Share, By Route, 2022 (E)
Figure 81: Mexico Market Value Share, By Mode, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Market Value Share, By Route, 2022 (E)
Figure 84: Brazil Market Value Share, By Mode, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Market Value Share, By Route, 2022 (E)
Figure 87: U. K. Market Value Share, By Mode, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Market Value Share, By Route, 2022 (E)
Figure 90: Germany Market Value Share, By Mode, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Market Value Share, By Route, 2022 (E)
Figure 93: France Market Value Share, By Mode, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Market Value Share, By Route, 2022 (E)
Figure 96: Italy Market Value Share, By Mode, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Market Value Share, By Route, 2022 (E)
Figure 99: Spain Market Value Share, By Mode, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Market Value Share, By Route, 2022 (E)
Figure 102: Russia Market Value Share, By Mode, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Market Value Share, By Route, 2022 (E)
Figure 105: China Market Value Share, By Mode, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Market Value Share, By Route, 2022 (E)
Figure 108: Japan Market Value Share, By Mode, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Market Value Share, By Route, 2022 (E)
Figure 111: South Korea Market Value Share, By Mode, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Market Value Share, By Route, 2022 (E)
Figure 114: India Market Value Share, By Mode, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Market Value Share, By Route, 2022 (E)
Figure 117: ASEAN Market Value Share, By Mode, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Market Value Share, By Route, 2022 (E)
Figure 120: Australia Market Value Share, By Mode, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Market Value Share, By Route, 2022 (E)
Figure 123: New Zealand Market Value Share, By Mode, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Market Value Share, By Route, 2022 (E)
Figure 126: GCC Countries Market Value Share, By Mode, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Market Value Share, By Route, 2022 (E)
Figure 129: Turkey Market Value Share, By Mode, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Market Value Share, By Route, 2022 (E)
Figure 132: South Africa Market Value Share, By Mode, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the novel drug delivery systems market?
The global novel drug delivery systems market stands at US$ 62.5 billion valuation.
What is the projected NDDS market value?
By 2027, the novel drug delivery systems market is expected to reach US$ 86 billion.
How will demand for novel drug delivery systems evolve?
Demand for novel drug delivery systems is slated to rise at 6.6% CAGR through 2027.
Which key market players are profiled in this Fact.MR analysis?
Astellas, Aspen, Lupin, Breckenridge Pharmaceuticals, Shire, Galen, 3M Company, Merck & Co. Inc., Teva Pharmaceuticals Industries Limited, and Abbott Laboratories are leading market players.
Which mode of administration will remain popular in NDDS?
In terms of mode, the novel drug delivery systems market will be dominated oral drug delivery systems.
Novel Drug Delivery Systems (NDDS) Market